American Century Companies’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-19,197
Closed -$2.46M 1452
2016
Q3
$2.46M Sell
19,197
-135
-0.7% -$17.3K ﹤0.01% 1028
2016
Q2
$2.41M Buy
+19,332
New +$2.22M ﹤0.01% 995
2014
Q3
Sell
-5,861
Closed -$891K 1536
2014
Q2
$891K Buy
5,861
+28
+0.5% +$3.73K ﹤0.01% 1241
2014
Q1
$751K Sell
5,833
-429
-7% -$66.7K ﹤0.01% 1277
2013
Q4
$1.09M Sell
6,262
-10
-0.2% -$1.72K ﹤0.01% 1220
2013
Q3
$1.01M Buy
6,272
+387
+7% +$60.9K ﹤0.01% 1224
2013
Q2
$781K Buy
+5,885
New +$831K ﹤0.01% 1255

Other funds holding ELGX

American Century Companies's ELGX Position: Q4 2016 in Review

American Century Companies sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 19,197 shares — an estimated $2.46M sold.

American Century Companies first reported a position in ELGX in Q2 2013 and held it in 7 quarters. The position peaked at $2.46M in Q3 2016. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • American Century Companies reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • American Century Companies sold 19,197 Endologix Inc shares in Q4 2016, an estimated $2.46M.
  • American Century Companies first reported a position in Endologix Inc in Q2 2013 and held it in 7 quarters.
  • American Century Companies's Endologix Inc position peaked at $2.46M in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on American Century Companies's 13F filing for Q4 2016, filed 3 Feb 2017.